Efficacy of PVX and PEGylated PVX as intratumoral immunotherapy is a research paper published in Materials Advances (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Materials Research Science and Engineering Center, University of California, San Diego
Grant: DMR-2011924
National Science Foundation
Grant: ECCS-1542148
National Institutes of Health
Grant: R01 CA224605
National Institutes of Health
Grant: R01 CA274640
National Science Foundation
Grant: 1542148
NNCI: San Diego Nanotechnology Infrastructure (SDNI)
National Science Foundation
Grant: 2011924
UC San Diego MRSEC: an NSF Materials Research Science and Engineering Center
National Institutes of Health
Grant: 5R01CA274640-03
Toward translation of a plant virus-based in situ vaccination nanotechnology
National Institutes of Health
Grant: 5R01CA224605-08
Dual-pronged nano-drug delivery using plant virus-like particles
FWCI
1.08
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Efficacy of PVX and PEGylated PVX as intratumoral immunotherapy